Segment Information (Tables)

12 Months Ended

Dec. 31, 2014

Financial Performance of Reporting Segments

The following table summarizes the financial performance of our reporting segments:



	Year Ended
	December 31, 2014						December 31, 2013						December 31, 2012
	Automation and Analytics		Medication Adherence ⁽¹⁾		Total		Automation and Analytics		Medication Adherence		Total		Automation and Analytics		Medication Adherence ⁽²⁾		Total
	(In thousands)
Revenues	$	354,095	$	86,805	$	440,900	$	302,917	$	77,668	$	380,585	$	260,160	$	53,867	$	314,027
Cost of revenues	151,327		55,713		207,040		129,314		47,872		177,186		111,599		31,840		143,439
Gross profit	202,768		31,092		233,860		173,603		29,796		203,399		148,561		22,027		170,588
Operating expenses	155,156		29,121		184,277		140,087		28,013		168,100		127,467		15,995		143,462
Income from operations	$	47,612	$	1,971	$	49,583	$	33,516	$	1,783	$	35,299	$	21,094	$	6,032	$	27,126

_________________________________________________


⁽¹⁾	Includes Surgichem results as of August 2014.


⁽²⁾	Includes MTS results as of May 2012.

Revenue by Geographical Location

Geographical Information



	Year Ended
	December 31, 2014		December 31, 2013		December 31, 2012
	(In thousands)
United States	$	394,234	$	334,412	$	287,716
Foreign countries ⁽¹⁾	46,666		46,173		26,311
Total revenues	$	440,900	$	380,585	$	314,027

_________________________________________________


⁽¹⁾	No individual country represented more than 10% of the respective totals.

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details